## Core Concept
Phenytoin is a widely used antiepileptic medication that belongs to the class of **sodium channel blockers**. It works by inhibiting the influx of sodium ions into neurons, thereby stabilizing neuronal membranes and preventing the spread of seizure activity. This mechanism is crucial for understanding its therapeutic effects and side effects.

## Why the Correct Answer is Right
The correct answer, which is not directly provided, needs to be inferred based on common knowledge about phenytoin. Typically, phenytoin is known for its **non-linear pharmacokinetics** due to the saturation of its primary metabolic pathway, which can lead to **zero-order kinetics** at therapeutic doses. This means that small increments in dose can lead to disproportionately large increases in plasma concentration, which is a critical consideration in its dosing.

## Why Each Wrong Option is Incorrect
- **Option A:** Without the specific details of option A, we can't directly address its accuracy. However, if it pertains to a known effect or characteristic of phenytoin, such as its efficacy in treating certain types of seizures or its common side effects (e.g., nystagmus, ataxia, gingival hypertrophy), and it's stated as false, it would be incorrect based on established pharmacology.
- **Option B:** Similarly, without specifics, if option B describes a true characteristic of phenytoin (like its metabolism primarily by the liver or its potential to cause hepatotoxicity), stating it as false would be incorrect.
- **Option C:** If option C suggests that phenytoin does not follow zero-order kinetics, this would be incorrect because phenytoin is a classic example of a drug that exhibits zero-order kinetics at therapeutic doses due to the saturation of its metabolic enzymes.
- **Option D:** If option D mentions a side effect or a pharmacokinetic property not attributed to phenytoin, and it's marked as false regarding phenytoin, the explanation would depend on the specific content of option D.

## Clinical Pearl / High-Yield Fact
A crucial point to remember about phenytoin is its **saturation kinetics**. At low doses, phenytoin is metabolized through **first-order kinetics**, but as doses increase and the enzymes responsible for its metabolism become saturated, it switches to **zero-order kinetics**. This means that beyond a certain dose, the plasma concentration of phenytoin increases disproportionately with small increments in dose, increasing the risk of toxicity.

## Correct Answer: D. (Assuming D is the false statement regarding a well-known incorrect attribute of phenytoin)